Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 59 (PPIAP59)

Target
PPIAP59
Molecular classification
Other (Pseudogene)
01

Overview

Peptidylprolyl isomerase A pseudogene 59 (PPIAP59) is classified as a human pseudogene with close sequence similarity to the protein-coding PPIA gene, which encodes cyclophilin A, an enzyme involved in protein folding, signal transduction, and immune response[1][6][7]. Unlike PPIA, PPIAP59 does not produce a functional protein and is not implicated in any characterized biological processes, drug interactions, or direct disease roles[10][2]. Pseudogenes such as PPIAP59 may have residual or regulatory roles at the RNA level (as non-coding RNAs), but current data provide no evidence for biological activity, disease relevance, or utility as a therapeutic target for PPIAP59[11]. If a functional or druggable target is desired, the focus should be on peptidylprolyl isomerase A (PPIA) rather than its pseudogene PPIAP59[1][10][2].

Other names
PPIAP59Peptidylprolyl isomerase A pseudogene 59HGNC: 53683NCBI Gene: 390956Ensembl: ENSG00000228674
02

Mechanism of action

None applicable — Inactive as a therapeutic target.

03

Biological functions

Pseudogenes are generally non-functional, but some may regulate gene expression at the RNA level (e.g., via ceRNA or siRNA functions)There is no evidence of protein function for PPIAP59.
04

Disease associations

Pseudogenes can sometimes act as regulators in disease contextsHowever, there is no disease-association or functional evidence for PPIAP59 specifically; reports for related pseudogenes like PPIAP22 highlight possible indirect disease roles but not for PPIAP59.
05

Safety considerations

None applicable — It is not therapeutically targeted.
06

Interacting drugs

None — PPIAP59 does not encode a protein, so no drugs interact with it
07

Biomarkers

None — There is no evidence that PPIAP59 is used as a biomarker or in patient selection.

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 59 (PPIAP59).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 59 (PPIAP59).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call